Neurocrine Bioscience buy Morgan Stanley
Start price
12.07.24
/
50%
€136.55
Target price
12.07.25
€155.89
Performance (%)
-19.19%
Price
13.09.24
€110.35
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -19.19%. This prediction currently runs until 12.07.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.846% | 1.846% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $160.00 to $170.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-11.47%
13.09.24
13.09.24